Abstract:Background: The induction of maternal inflammation in mice leads to fetal injury that is believed to be IL-6 dependent. The fetal inflammatory response, defined by elevated fetal or amniotic fluid IL-6, has been described as a potential mechanism for subsequent fetal injury. The role of maternal IL-6 production and signaling in the fetal IL-6 response is currently unclear. Methods: Genetic and anti-IL-6 antibody strategies were used to systematically block the maternal IL-6 response during inflammation. Chorioamnionitis was induced using intraperitoneal injection of lipopolysaccharide (LPS) at mid gestation (E14.5) and late gestation (E18.5). This model was used in pregnant C57Bl/6 dams, IL6-/- dams, C57Bl/6 dams treated with anti-IL-6 (blocks both classical and trans-signaling) or anti-gp130 antibodies (blocks trans-signaling only) and IL6+/- dams. Six hours following LPS injection, maternal serum, placental tissue, amniotic fluid and fetal tissue or serum were collected. A bead-based multiplex assay was used to evaluate levels of IL-6, KC, IL-1β, TNF, IL-10, IL-22, IFN-γ, IL-13 and IL-17A. Results: Chorioamnionitis in C57Bl/6 dams was characterized by elevated maternal serum levels of IL-6, KC and IL-22 with litter loss during mid gestation. The fetal response to maternal inflammation in C57Bl/6 mice was primarily characterized by elevated levels of IL-6, KC and IL-22 in the placenta, amniotic fluid and fetus during both mid and late gestation. A global IL-6 knockout (IL6-/-) eradicated the maternal, placental, amniotic fluid and fetal IL-6 response to LPS during mid and late gestation and improved litter survival, while minimally influencing the KC or IL-22 responses. Blocking maternal classical IL-6 signaling in C57Bl/6 dams at the time of LPS exposure diminished the maternal, placental, amniotic fluid and fetal IL-6 response during mid and late gestation, while blocking maternal IL-6 trans-signaling only affected fetal IL-6 expression. To evaluate whether maternal IL-6 was crossing the placenta and reaching the fetus, IL-6+/- dams were utilized in the chorioamnionitis model. IL-6+/- dams mounted a systemic inflammatory response following injection with LPS, characterized by elevated IL-6, KC and IL-22. IL-6-/- pups born to IL6+/- dams had decreased amniotic fluid levels of IL-6 and undetectable levels of fetal IL-6 compared to IL-6+/+ littermate controls. Conclusion: The fetal response to systemic maternal inflammation is dependent upon maternal IL-6 signaling, but maternal IL-6 is not crossing the placenta and reaching the fetus at detectable levels.

Maternal inflammation regulates fetal emergency myelopoiesis

Retraction Notice to “the Effect of Maternal Infection on Cognitive Development and Hippocampus Neuronal Apoptosis, Proliferation and Differentiation in the Neonatal Rats” [neuroscience 246 (2013) 422–434]

The fetal response to maternal inflammation is dependent upon maternal IL-6 in a murine model

Placental dysfunction influences fetal monocyte subpopulation gene expression in preterm birth

Fetal brain response to maternal inflammation requires microglia

LPS-induced maternal inflammation promotes fetal leukocyte recruitment and prenatal organ infiltration in mice

Integrated Review of Cytokines in Maternal, Cord, and Newborn Blood: Part II— Associations With Early Infection and Increased Risk of Neurologic Damage in Preterm Infants

Both maternal IFNγ exposure and acute prenatal infection with Toxoplasma gondii activate fetal hematopoietic stem cells

Beclin 1 Prevents ISG15-mediated Cytokine Storms to Secure Fetal Hematopoiesis and Survival

Inflammation-induced alterations in maternal-fetal Heme Oxygenase (HO) are associated with sustained innate immune cell dysregulation in mouse offspring

Maternal Circadian Rhythm Disruption Affects Neonatal Inflammation Via Metabolic Reprograming of Myeloid Cells

Transitory presence of myeloid-derived suppressor cells in neonates is critical for control of inflammation

Prenatal inflammation suppresses blood Th1 polarization and gene clusters related to cellular energy metabolism in preterm newborns

Continuous activation of polymorphonuclear myeloid-derived suppressor cells during pregnancy is critical for fetal development

The Fetomaternal Dependency of Cord Blood Interleukin-6

HMGB1 promotes a p38MAPK associated non-infectious inflammatory response pathway in human fetal membranes

Activation of iNKT Cells at the Maternal–Fetal Interface Predisposes Offspring to Cardiac Injury

The role of interleukin-1 in perinatal inflammation and its impact on transitional circulation

Neonatal inflammation impairs developmentally-associated microglia and promotes a highly reactive microglial subset

TLR8‐activating miR‐146a‐3p is an intermediate signal contributing to fetal membrane inflammation in response to bacterial LPS

Converging cytokine and metabolite networks shape asymmetric T cell fate at the term human maternal-fetal interface